FR2404014A1 - Nouveaux steroides et leur procede de preparation - Google Patents

Nouveaux steroides et leur procede de preparation

Info

Publication number
FR2404014A1
FR2404014A1 FR7817206A FR7817206A FR2404014A1 FR 2404014 A1 FR2404014 A1 FR 2404014A1 FR 7817206 A FR7817206 A FR 7817206A FR 7817206 A FR7817206 A FR 7817206A FR 2404014 A1 FR2404014 A1 FR 2404014A1
Authority
FR
France
Prior art keywords
hydroxy
cholecalciferol
cholesterol
intermediates
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7817206A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of FR2404014A1 publication Critical patent/FR2404014A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Pour synthétiser l'hydroxy-25 cholestérol et l'hydroxy-25 cholécalciférol à partir de matières premières dérivant de la bile des animaux, on transforme l'acide hyodésoxycholique ou un de ses esters en un ester alkylique d'acide hydroxy-3 beta DELTA 5-cholénique que l'on transforme en hydroxy-3 beta cyano-25 DELTA 5-cholène selon une série de stades où l'on stabilise le noyau stérol par mise en place d'un groupe protecteur en position 3, puis on allonge la chaîne carbonée en position 4 par un radical cyanure en position 25; on soumet le composé ainsi formé à une série de réactions le transformant en hydroxy-25 déhydro-7 cholestérol, que l'on peut ensuite irradier par la lumière ultraviolette pour obtenir l'hydroxy-25 cholécalciférol; l'invention décrit de nouveaux procédés améliorés pour préparer ces produits finals et de nouveaux composés formés comme intermédiaires ainsi que des procédés pour préparer ces intermédiaires. L'invention s'applique en particulier à une synthèse industrielle utilisant des appareillages courants et des matières premières peu coûteuses pour préparer, avec des rendements élevés, de l'hydroxy-25 cholestérol ou de l'hydroxy-25 cholécalciférol.
FR7817206A 1977-07-18 1978-06-08 Nouveaux steroides et leur procede de preparation Withdrawn FR2404014A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/816,478 US4183852A (en) 1977-07-18 1977-07-18 Process for preparing 25-hydroxycholesterol

Publications (1)

Publication Number Publication Date
FR2404014A1 true FR2404014A1 (fr) 1979-04-20

Family

ID=25220729

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7817206A Withdrawn FR2404014A1 (fr) 1977-07-18 1978-06-08 Nouveaux steroides et leur procede de preparation

Country Status (7)

Country Link
US (1) US4183852A (fr)
JP (1) JPS5422359A (fr)
CA (1) CA1150238A (fr)
DE (1) DE2830019A1 (fr)
FR (1) FR2404014A1 (fr)
GB (1) GB1582678A (fr)
IT (1) IT1097264B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL60270A0 (en) * 1979-06-14 1980-09-16 Diamond Shamrock Corp Preparation of 25-ydroxycholesterol
US4336193A (en) * 1980-08-04 1982-06-22 Wisconsin Alumni Research Foundation Process for preparing vitamin D-lactones
US4351767A (en) * 1981-06-29 1982-09-28 Kaiser Emil T Synthesis of 24,25-dihydroxycholesterol
US4411833A (en) * 1982-05-26 1983-10-25 Wisconsin Alumni Research Foundation Method for preparing 26,26,26,27,27,27-hexafluoro-1α,25-dihydroxycholesterol
CA1312637C (fr) * 1987-09-17 1993-01-12 Ronald C. Banko Dispositif de rangement d'objets en piles
JPH036144U (fr) * 1989-06-08 1991-01-22
WO1993016607A1 (fr) * 1992-02-28 1993-09-02 The Regents Of The University Of California Procede de decholesterolisation du jaune d'×uf avec production simultanee de cholesterol en tant que sous-produit
AU3068497A (en) * 1996-05-06 1997-11-26 Bionumerik Pharmaceuticals, Inc. Process for preparing 27-hydroxy cholesterol and related derivatives
AU2003268260B2 (en) * 2002-08-29 2008-04-10 The Regents Of The University Of California Agents and methods for enhancing bone formation
JP4438308B2 (ja) * 2003-04-07 2010-03-24 三菱化学株式会社 ステロイド化合物の製造方法
WO2005020928A2 (fr) * 2003-08-29 2005-03-10 The Regents Of The University Of California Agents et procedes permettant d'ameliorer la formation osseuse a l'aide d'oxysterols combines a des proteines morphogeniques osseuses
ATE422028T1 (de) * 2005-04-23 2009-02-15 Ixetic Mac Gmbh Axialkolbenmaschine
AU2006284650A1 (en) * 2005-09-02 2007-03-08 The Regents Of The University Of California Osteogenic and anti-adipogenic oxysterols
US9670244B2 (en) * 2006-02-27 2017-06-06 The Regents Of The University Of California Oxysterol compounds and the hedgehog pathway
WO2008011071A2 (fr) * 2006-07-19 2008-01-24 The Regents Of The University Of California Interactions des voies de signaux hedgehog et du récepteur x hépatique
EP2111225A4 (fr) 2006-12-19 2010-02-10 Univ California Inhibition de l'expression de ppar gamma par des oxystérols ostéogènes spécifiques
EP2146724A2 (fr) * 2007-03-16 2010-01-27 The Regent of the University of California Rôle de la signalisation par hérisson dans l'athérosclérose et les maladies cardiovasculaires
CN101951915A (zh) * 2007-12-03 2011-01-19 加利福尼亚大学董事会 用于刺猬蛋白信号、骨诱导、抗脂肪形成和wnt信号的激活的氧固醇
FI2753632T3 (fi) 2011-09-08 2023-08-02 Sage Therapeutics Inc Neuroaktiivisia steroideja, koostumuksia ja niiden käyttöjä
WO2013169399A1 (fr) 2012-05-07 2013-11-14 The Regents Of The University Of California Oxy133, un analogue de l'oxystérol, induisant l'ostéo-genèse et la signalisation hedgehog et inhibant l'adipogenèse
RS67266B1 (sr) * 2013-03-13 2025-10-31 Sage Therapeutics Inc Neuroaktivni steroidi i postupci za njihovu upotrebu
US9683009B2 (en) 2013-05-02 2017-06-20 The Regents Of The University Of California Bone-selective osteogenic oxysterol-bone targeting agents
FI3828194T3 (fi) 2015-07-06 2025-07-17 Sage Therapeutics Inc Oxysteroleita ja menetelmiä niiden käyttämiseksi
MX390271B (es) 2015-07-06 2025-03-20 Sage Therapeutics Inc Oxiesteroles y metodos de uso de los mismos
MA42409A (fr) * 2015-07-06 2018-05-16 Sage Therapeutics Inc Oxystérols et leurs procédés d'utilisation
WO2017193046A1 (fr) 2016-05-06 2017-11-09 Sage Therapeutics, Inc. Oxystérols et méthodes d'utilisation associées
LT3481846T (lt) 2016-07-07 2021-08-25 Sage Therapeutics, Inc. 11-pakeistieji 24-hidroksisteroliai, skirti naudoti gydant su nmda susijusias būkles
JP7149266B2 (ja) 2016-09-30 2022-10-06 セージ セラピューティクス, インコーポレイテッド C7置換オキシステロールおよびnmdaモジュレーターとしての方法
EP3965773B1 (fr) 2019-05-09 2025-12-31 Fermenta Biotech Limited Nouveau procédé de synthèse de 25-oh cholestérol/calcifédiol à partir de phytostérol
CN112897512B (zh) * 2021-02-03 2022-11-04 中国科学院物理研究所 碳纳米管分散体和选择性分离碳纳米管的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3257384A (en) * 1963-01-04 1966-06-21 Upjohn Co Derivatives of 25-azacholesterol and 22-oxa-25-azacholesterol
US3833622A (en) * 1969-03-17 1974-09-03 Upjohn Co Crystalline 25-hydroxycholecalciferol hydrate and structurally related compounds

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
EXBK/73 *

Also Published As

Publication number Publication date
IT7824940A0 (it) 1978-06-23
JPS5422359A (en) 1979-02-20
DE2830019A1 (de) 1979-01-25
IT1097264B (it) 1985-08-31
JPS5751840B2 (fr) 1982-11-04
GB1582678A (en) 1981-01-14
US4183852A (en) 1980-01-15
CA1150238A (fr) 1983-07-19

Similar Documents

Publication Publication Date Title
ATE191467T1 (de) Herstellung von amidoester-verbindungen
DE2757157C3 (de) Verfahren zur Herstellung von 16 a -alkylierten Steroiden
DE1668784B2 (de) Verfahren zur herstellung von aldehyden oder ketonen durch oxydation primaerer oder sekundaerer alkohole
FR2411846A1 (fr) Procede de preparation de nouveaux steroides et produits obtenus par le procede
US2498390A (en) Preparation of 7-dehydrocholesteryl esters
ATE126222T1 (de) Verfahren zur herstellung von tetrahydrofuran und alpha-butyrolacton.
EP0443000B1 (fr) Procede de production de derives de progesterone
DE3490427T (de) 1,23-Dihydroxyvitamin-D-Verbindungen
DE102004040702B4 (de) Verfahren zur Herstellung eines Dioxazin-Derivats
DE2409971C3 (de) 5-Cholestenderivate und Verfahren zu ihrer Herstellung
EP0005523B1 (fr) D-Homostéroides, procédé pour leur préparation
EP0036159B1 (fr) Acide 4-(2,5-dihydroxyphényl-1)crotonique et ses dérivés et procédés pour la préparation de ces composés
DE2331044A1 (de) Diphenylmethan-derivate und verfahren zu deren herstellung
EP0078766A1 (fr) Procédé de préparation d'acide aminométhylphosphonique
Bartoli et al. Reactivity of acylsilane phenylhydrazones with phosphorus trichloride
DE3101317A1 (de) "9-halogenandrosten-3-on-derivate, verfahren zu ihrer herstellung und ihre verwendung zur lokalen bekaempfung von entzuendungen"
DE953975C (de) Verfahren zur Herstellung von in 4(5)-Stellung ungesaettigten 3-Ketopregnanen
DE3040634A1 (de) Verfahren zur herstellung von 3 (alpha) -hydroxy-5- (beta) -pregnan-11,20-dion
Brown et al. 8-Aza Steroids. IV. 1 8-Aza-19-norprogestogens
DE1493086C3 (fr)
DE900935C (de) Verfahren zur Herstellung von 12-Brom-3-acyloxy-5,7,9(11)-pregnatrien-20-on-additionsprodukten
DE4319998A1 (de) Verfahren zur Herstellung von Derivaten des Estra-1,3,5(10),14-tetraen-3,17alpha-diols
CH651054A5 (de) Verfahren zur trennung von gemischen von 4-androsten-3,17-dion und 1,4-androstadien-3,17-dion.
DE1618897B1 (de) Verfahren zur Herstellung von 6-Keto-14 Alfa-hydroxy-Delta7-steroiden
SU549964A1 (ru) Способ получени рацемического биотина

Legal Events

Date Code Title Description
ST Notification of lapse